½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > СÊó¿¹ACSF2µ¥¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • СÊó¿¹ACSF2µ¥¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW6090
    • Ó¦Óà : ½öÏÞÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ : СÊó¿¹ACSF2µ¥¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ : Anti-ACSF2 mouse monoclonal antibody

±ð      Ãû : ACSMW; AVYV493

´¢      ´æ : Àä¶³£¨-20¡æ£© ±Ü¹â

¿¹      Ô­ : ACSF2

ËÞ      Ö÷ : Mouse

·´Ó¦ÖÖÊô : Human

Ïà¹ØÀà±ð : Ò»¿¹

±ê  ¼Ç Îï : Unconjugate

¿Ë¡ÀàÐÍ : mouse monoclonal





¼¼Êõ¹æ¸ñ

Background:

ACSF2 (acyl-CoA synthetase family member 2), also known as PPAR binding, long chain fatty acid acyl Co-A ligase like, is a 615 amino acid protein belonging to the ATP-dependent AMP-binding enzyme family. Encoded by a gene that maps to human chromosome 17q21.33, ACSF2 contains a PPAR -recognition element in its promoter sequence. Exhibiting mitochondrial subcellular localization, ACSF2 forms a thioester with CoA, thereby catalyzing the initial reaction in fatty acid metabolism. ACSF2 participates in ATP binding, ligase activity and adipodyte differentiation, and displays a preference for medium-chain substrates. ACSF2 may be a potential prognostic molecular marker for breast cancer.

Applications:

WB, IHC, IF, FC

Name of antibody:

ACSF2

Immunogen:

Fusion protein of human ACSF2

Full name:

acyl-CoA synthetase family member 2 (ACSF2), transcript variant 2

Synonyms:

ACSMW; AVYV493

SwissProt:

Q96CM8

IHC positive control:

carcinoma of human lung tissue and carcinoma of human thyroid tissue

IHC Recommend dilution:

30-150

WB Predicted band size:

68 kDa

WB Positive control:

HepG2, MCF-7 cell lysates

WB Recommended dilution:

200-1000

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿